TGFB1 and cancer: Derangement of the TGFβ1 signal transduction pathway, mediated by mutations or polymorphisms of its receptors and/or of the transduction molecules, SMADs, is considered to play a primary role in the development and progression of several types of cancer in humans [13], [14].